UnitedHealth Group Incorporated $UNH Stock Sold by Diversified Trust Co

Diversified Trust Co trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.7% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 37,680 shares of the healthcare conglomerate’s stock after selling 13,751 shares during the quarter. Diversified Trust Co’s holdings in UnitedHealth Group were worth $13,832,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. General Partner Inc. purchased a new stake in UnitedHealth Group in the third quarter worth approximately $512,000. PBCay One RSC Ltd bought a new stake in UnitedHealth Group in the 1st quarter worth approximately $14,343,000. Lee Johnson Capital Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter valued at $6,180,000. Kinsale Capital Group Inc. lifted its holdings in shares of UnitedHealth Group by 13.4% during the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock valued at $16,006,000 after buying an additional 4,557 shares during the period. Finally, Kelleher Financial Advisors lifted its holdings in shares of UnitedHealth Group by 135.9% during the 2nd quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock valued at $2,284,000 after buying an additional 3,166 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by company insiders.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Mizuho lifted their price objective on UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Piper Sandler increased their target price on UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a report on Wednesday, October 14th. The Goldman Sachs Group raised their target price on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Raymond James Financial reaffirmed an “outperform” rating and set a $450.00 price target on shares of UnitedHealth Group in a research report on Thursday, October 15th. Finally, Robert W. Baird lowered their price objective on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $463.93.

Key Stories Impacting UnitedHealth Group

Here are a few of the latest stories about UNH:

• Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
• Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
• Negative Sentiment: Optum Rx’s prescription volumes declined, highlighting ongoing membership-related pressure even as segment earnings improved. Whether efficiencies and biosimilar adoption can sustain profit growth will matter to investors. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?

UnitedHealth Group Trading Up 0.6%

Shares of UNH stock opened at $407.62 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market cap of $365.23 billion, a price-to-earnings ratio of 23.28, a PEG ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a fifty day moving average price of $391.36 and a 200-day moving average price of $365.66.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period last year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.